<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>小桔灯网 - 创投论道</title>
    <link>https://www.iivd.net/portal.php?mod=list&amp;catid=88</link>
    <description>Latest 20 articles of 创投论道</description>
    <copyright>Copyright(C) 小桔灯网</copyright>
    <generator>Discuz! Board by Comsenz Inc.</generator>
    <lastBuildDate>Thu, 30 Apr 2026 20:32:01 +0000</lastBuildDate>
    <ttl>60</ttl>
    <image>
      <url>https://www.iivd.net/static/image/common/logo_88_31.gif</url>
      <title>小桔灯网</title>
      <link>https://www.iivd.net/</link>
    </image>
    <item>
      <title>吉因加IPO背后，挑战与机遇并存</title>
      <link>https://www.iivd.net/article-43613-1.html</link>
      <description><![CDATA[实质性跨越，还是其在AI大浪潮下利用AI大模型整合肿瘤医学领域新的探索]]></description>
      <category>创投论道</category>
      <author>小李叨叨</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202601/09/103354hhuoibb8fz6x5rr0.png" length="68496" type="image/jpeg" />
      <pubDate>Fri, 09 Jan 2026 02:34:23 +0000</pubDate>
    </item>
    <item>
      <title>沐曦3000亿，投资人迎来超级回报</title>
      <link>https://www.iivd.net/article-43406-1.html</link>
      <description><![CDATA[要在热闹中保持冷静，在悲观中敢于出手]]></description>
      <category>创投论道</category>
      <author>投资界</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202512/19/103323jlpeinj4orrezi7o.jpg" length="201522" type="image/jpeg" />
      <pubDate>Fri, 19 Dec 2025 02:33:27 +0000</pubDate>
    </item>
    <item>
      <title>负债229%，“医械黑马”再次冲击港股IPO</title>
      <link>https://www.iivd.net/article-43155-1.html</link>
      <description><![CDATA[随着港股生物科技板块的估值日益理性，只有那些真正拥有技术壁垒和商业化潜力的企业，才能在这场残酷的竞争中笑到最后。]]></description>
      <category>创投论道</category>
      <author>医疗器械创新网</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202511/20/095442bupwjpp0k8500gop.jpg" length="1152308" type="image/jpeg" />
      <pubDate>Thu, 20 Nov 2025 01:54:55 +0000</pubDate>
    </item>
    <item>
      <title>分享会：如何在美国居家检测市场抢占先机？</title>
      <link>https://www.iivd.net/article-43059-1.html</link>
      <description><![CDATA[助力中国IVD企业在全球检测市场取得更大突破]]></description>
      <category>创投论道</category>
      <author>严选IVD原料</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202511/06/140109ycqchh4eenekwh5o.jpg" length="1366984" type="image/jpeg" />
      <pubDate>Thu, 06 Nov 2025 06:01:14 +0000</pubDate>
    </item>
    <item>
      <title>今年国办1号文件，震撼创投圈</title>
      <link>https://www.iivd.net/article-39832-1.html</link>
      <description><![CDATA[这一次国务院办公厅印发的《指导意见》，势必会深刻影响中国创投行业]]></description>
      <category>创投论道</category>
      <author>投资界</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202501/10/171726v73ehwld5y4dszch.png" length="608039" type="image/jpeg" />
      <pubDate>Fri, 10 Jan 2025 09:15:00 +0000</pubDate>
    </item>
    <item>
      <title>关于投诉J投资人事件的澄清与致歉</title>
      <link>https://www.iivd.net/article-38823-1.html</link>
      <description><![CDATA[本文是一则澄清和致歉。]]></description>
      <category>创投论道</category>
      <author>川越周期</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202410/29/102140lvpnus0p3c8lp3u4.png" length="274" type="image/jpeg" />
      <pubDate>Tue, 29 Oct 2024 02:21:00 +0000</pubDate>
    </item>
    <item>
      <title>海通证券，风暴空前 | 棱镜</title>
      <link>https://www.iivd.net/article-36212-1.html</link>
      <description><![CDATA[上海黄浦区中山南路海通证券办公楼，“海通”之名，取自其筹建方交通银行上海分行。来源：视觉中国作者｜温世君编辑 | 王伟凯出品 | 棱镜·腾讯小满工作室海通证券的高管们正在经历职业生涯最艰难的时刻。 但即便背  ... ...]]></description>
      <category>创投论道</category>
      <author>棱镜丨作者： 温世君</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202404/14/015819ojhb5bbhjjjbj3dh.png" length="5924" type="image/jpeg" />
      <pubDate>Sat, 13 Apr 2024 17:58:00 +0000</pubDate>
    </item>
    <item>
      <title>A股超重磅！刚刚，三大交易所重大发布！又一次见证历史</title>
      <link>https://www.iivd.net/article-36204-1.html</link>
      <description><![CDATA[中国基金报记者 刘明见习记者闻言4月12日下午，上交所、深交所、北交所相继发布多项公开征求意见的规则，有针对性完善发行上市、信息披露、股份减持、分红、退市等制度安排；加强股票发行上市审核、发行承销、上市公 .. ...]]></description>
      <category>创投论道</category>
      <author>中国基金报</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202404/14/013151xtbbc8rfuwnw8if8.gif" length="2060934" type="image/jpeg" />
      <pubDate>Sat, 13 Apr 2024 17:32:07 +0000</pubDate>
    </item>
    <item>
      <title>全是干货：8大经验帮初创仪器公司快速搭建基本管理体系</title>
      <link>https://www.iivd.net/article-36020-1.html</link>
      <description><![CDATA[收到万字长文的感动“这是一篇一万字的长篇投稿，更是一部初创公司的创业指导手册。]]></description>
      <category>创投论道</category>
      <author>进化风暴丨作者：百奥唐小僧</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202404/01/230621bu6yx9pixqubzbcq.jpg" length="100796" type="image/jpeg" />
      <pubDate>Mon, 01 Apr 2024 15:06:00 +0000</pubDate>
    </item>
    <item>
      <title>今年还没IVD企业A股上市？遇冷</title>
      <link>https://www.iivd.net/article-34500-1.html</link>
      <description><![CDATA[除相关性较强的ICL企业艾迪康外，上市IVD企业数仍旧为零。]]></description>
      <category>创投论道</category>
      <author>医业观察</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202311/29/171741pg2opr97sgkp9vy2.png" length="66869" type="image/jpeg" />
      <pubDate>Wed, 29 Nov 2023 09:17:44 +0000</pubDate>
    </item>
    <item>
      <title>2023已经过半，潮水退去，人人都在裸泳</title>
      <link>https://www.iivd.net/article-33098-1.html</link>
      <description><![CDATA[专注创新药/biotech领域早期的孵化与投资。]]></description>
      <category>创投论道</category>
      <author>Biotech投资观察苏丨作者</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202307/08/192926wgefcfxe5ewfoiic.png" length="102368" type="image/jpeg" />
      <pubDate>Sat, 08 Jul 2023 11:30:00 +0000</pubDate>
    </item>
    <item>
      <title>守得云开方见日，多重利好下IVD股价大涨，仍有众多投资机会</title>
      <link>https://www.iivd.net/article-30711-1.html</link>
      <description><![CDATA[在IVD调整近2年后，终于出现了一次大涨，此次体外诊断股价大涨正是在多重利好叠加下出现的。]]></description>
      <category>创投论道</category>
      <author>李小白在医械圈奋斗</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202210/18/172745uqrnqw9o4q0cwr91.jpg" length="2794137" type="image/jpeg" />
      <pubDate>Tue, 18 Oct 2022 09:27:53 +0000</pubDate>
    </item>
    <item>
      <title>IVD行业丨IPO排队情况总结</title>
      <link>https://www.iivd.net/article-30431-1.html</link>
      <description><![CDATA[IPO合计募集102.26亿元！IVD依然是不可错过的黄金赛道]]></description>
      <category>创投论道</category>
      <author>高禾投资</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202209/13/111912x1w0ggdz1avgx8vr.png" length="79488" type="image/jpeg" />
      <pubDate>Tue, 13 Sep 2022 03:19:17 +0000</pubDate>
    </item>
    <item>
      <title>IPO拟募资25亿！国产基因测序设备第一股来了/基因测序产业链研究报告</title>
      <link>https://www.iivd.net/article-30286-1.html</link>
      <description><![CDATA[上游环节二代测序仪呈现寡头竞争格局，市场份额和营收利润预期确定性较强]]></description>
      <category>创投论道</category>
      <author>高禾投资 | 作者：高禾投资研</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202208/25/165809c24m7yggvtzcbucl.png" length="473650" type="image/jpeg" />
      <pubDate>Thu, 25 Aug 2022 09:01:52 +0000</pubDate>
    </item>
    <item>
      <title>医械公司IPO规范中提速</title>
      <link>https://www.iivd.net/article-30206-1.html</link>
      <description><![CDATA[作为注册制改革受益最大的板块之一，近年来医械类上市公司逐渐成为生物医药行业IPO的主力。]]></description>
      <category>创投论道</category>
      <author>医药经济报</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202208/16/153447j50nvhmk4g449zvk.jpg" length="462137" type="image/jpeg" />
      <pubDate>Tue, 16 Aug 2022 07:37:26 +0000</pubDate>
    </item>
    <item>
      <title>他们说，GP、LP亟需来一场“内生性”变革</title>
      <link>https://www.iivd.net/article-30139-1.html</link>
      <description><![CDATA[今年以来，股权投资界思考得更多的，或许是关于“变与不变”、“如何迎变”的问题。]]></description>
      <category>创投论道</category>
      <author>泛地产资管圈</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202208/10/111638m886qr0eedq6q6ce.jpg" length="2013602" type="image/jpeg" />
      <pubDate>Wed, 10 Aug 2022 03:16:42 +0000</pubDate>
    </item>
    <item>
      <title>阿里巴巴的IVD版图！</title>
      <link>https://www.iivd.net/article-30108-1.html</link>
      <description><![CDATA[8月4日，阿里巴巴集团公布2023财年第一季度(即2022年第二季度)业绩。中国零售商业业务项下，直营及其他收入为人民币647.1亿元，同比增长8%。财报显示，该增长主要由盒马及阿里健康等业务的直营收入增长所贡献。近年 ... ...]]></description>
      <category>创投论道</category>
      <author>MIR仪器与试剂</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202208/07/235821zwr9r03q193rxnbq.jpeg" length="78082" type="image/jpeg" />
      <pubDate>Sun, 07 Aug 2022 15:58:28 +0000</pubDate>
    </item>
    <item>
      <title>IVD企业科创板上市注册情况一览</title>
      <link>https://www.iivd.net/article-30107-1.html</link>
      <description><![CDATA[科创板开板以来，IVD基因相关企业纷纷登陆，也曾造就诸多股票传奇。有人得意，有人失意。最近世和基因、近岸蛋白、翌圣生物被牵连“中止”引发关注。回顾历史，还有吉凯基因、乐普诊断、丹娜生物被“终止”后就未有 ... ...]]></description>
      <category>创投论道</category>
      <author>基因江湖</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202208/07/235314ynncfsx7488nnf82.jpg" length="631893" type="image/jpeg" />
      <pubDate>Sun, 07 Aug 2022 15:54:52 +0000</pubDate>
    </item>
    <item>
      <title>医疗器械领域投资机构盘点：澳银资本</title>
      <link>https://www.iivd.net/article-29784-1.html</link>
      <description><![CDATA[澳银资本持续关注并重点投资于医学健康、先进制造、信息技术、能源材料等新兴技术领域中具有高成长潜力的初创企业。]]></description>
      <category>创投论道</category>
      <author>思宇MedTech | 整理：</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202207/12/152506klupoukfexd5fuex.png" length="1064229" type="image/jpeg" />
      <pubDate>Tue, 12 Jul 2022 07:30:03 +0000</pubDate>
    </item>
    <item>
      <title>Moderna背后的另类风投，十年25个IPO是如何练成的？</title>
      <link>https://www.iivd.net/article-29633-1.html</link>
      <description><![CDATA[靠Moderna一战成名的“另类”投资机构。]]></description>
      <category>创投论道</category>
      <author>MedTrend医趋势</author>
<enclosure url="https://www.iivd.net/data/attachment/portal/202206/29/145715hjlflf6dj98fdp5w.jpg" length="108278" type="image/jpeg" />
      <pubDate>Wed, 29 Jun 2022 06:57:19 +0000</pubDate>
    </item>
  </channel>
</rss>